On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

The Voice of Harm Reduction User Rights Edition, November 2011
This issue is dedicated to the Rights of People Who Use Drugs. In the content you will find: Message from an Expert: Mat Southwell, INPUD and Olga Belyaeva, EHRN Steering Committee member; Completing Laws with Rights, review by Mikhail Golichenko, Canadian HIV/AIDS Legal Network and more
Amphetamine Type Stimulants and Harm Reduction
Problematic use of amphetamine-type stimulants (ATS)2 has become a significant health and social problem in East and Southeast Asia, in particular the use of methamphetamine, the most potent amphetamine derivative and most widely used substance in the region.
Prevention of torture by doctors and organisations
The report draws attention to the many instances of medical professionals who, often at personal risk, seek to prevent and mitigate the effects of torture.
Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy
Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines.
INPUD Statement and Position Paper on language,identity, inclusivity and discrimination
"INPUD is a global network that advocates for the human rights of people who use drugs. As with earlier movements for equality - notably those relating to gender, race, ethnicity, sexuality and disability - language is one domain through which identity is expressed and where oppression may arise."
Troops Becoming Drug Addicts - What is the Solution?
An interview regarding the denial by U.S. military's insurance scheme to cover maintenance pharmacotherapy treatment for addiction.
Profile: Kamiar and Arash Alaei - Championing HIV/AIDS initiatives in Iran
A profile in The Lancet (Vol 378, 16 July 2011) of Drs. Arash and Kamiar Alaei.
IDHDP Statement: In support of the Report of the Global Commission on Drugs
Statement in support of the Report of the Global Commission on Drugs
Test and treat this silent killer
The scourge of the hepatitis C virus in the United States is woefully underestimated. Brian R. Edlin states it is time the infection is given the priority it demands.
Drug Policy in Portugal: The Benefits of Decriminalizing Drug Use
The changes in Portugal’s drug law and national policy and how this has marked a turning point for the country and a milestone in international drug policy.
Share this on: